Across the recent three months, 6 analysts have shared their insights on ResMed RMD, expressing a variety of opinions spanning from bullish to bearish. The following table provides a quick ...

ResMed shares soared amid an upbeat outlook for sleep apnea treatments, while Insulet shares jumped following a new FDA approval. Shares of Paramount Global fell after media executive Edgar ...

ResMed's management isn't just brushing off the threat of weight loss drugs — it's doubling down on the theory that they'll benefit the company's sleep apnea business. 'We believe that the growth in ...

Investors need to buy shares before the ex-dividend date to gain access to that dividend. For Resmed, the shares will go ex-dividend on 8 May 2024, which is next Wednesday. That means investors ...